Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis

Affiliations

• ¹ Centre for Neuroscience, Surgery & Trauma, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
• ² Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.
• ³ Department of Neurology, Institute of Translational Neurology, University of Münster, Münster, Germany.
• ⁴ Department of Neurology, IdISSC, Hospital Universitario Clinico San Carlos, Madrid, Spain.
• ⁵ Departamento de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
• ⁶ Laboratory of Synaptic Immunopathology, Department of Systems Medicine, Tor Vergata University, Rome, Italy.
• ⁷ Unit of Neurology and Neurorehabilitation, IRCCS Neuromed, Pozzilli, Italy.
• ⁸ Clinical Research Services, Cytel Inc., Geneva, Switzerland.
• ⁹ Neurology & Immunology, Ares Trading S.A., Eysins, Switzerland (an affiliate of Merck KGaA).